Taken together, the study on RasGRP4 and our study focused on RasGRP1 and RasGRP3 bring new insights into a regulatory function of the RasGRP protein family in FLS and/or in immune cells from RA patients, thereby representing a potential target in RA. This evidence concerns the gene RASGRP3 and rheumatoid arthritis.